Lv11
20 积分 2024-01-25 加入
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
6个月前
已完结
An overview of phosphodiesterase 9 inhibitors: Insights from skeletal structure, pharmacophores, and therapeutic potential
11个月前
已完结
Current and emerging therapies for Achondroplasia: The dawn of precision medicine
11个月前
已完结
Vosoritide therapy in children with achondroplasia aged 3−59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial
11个月前
已关闭
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
1年前
已完结
An overview of phosphodiesterase 9 inhibitors: Insights from skeletal structure, pharmacophores, and therapeutic potential
1年前
已完结
皖公网安备34019202002308
